Neuropathy, womens' health, and socioeconomic aspects of diabetes

Diabetes Care

Volumn 25, Issue 6, 2002, Pages 1085-1094

  Bloomgarden, Zachary T ^a,b  

^a Mount Sinai School of Medicine ^*

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; DIACYLGLYCEROL; EPALRESTAT; FIDARESTAT; GLUCOSE; IDITOL DEHYDROGENASE; METHYLGLYOXAL; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SORBITOL; ZENARESTAT;

ARTERIOLE; CONFERENCE PAPER; DENSITY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE MODEL; ENDOTHELIUM; HEALTH; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; ISCHEMIA; KIDNEY CORTEX; KIDNEY DISEASE; MICROANGIOPATHY; MYELINATED NERVE; NERVE BIOPSY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVE FUNCTION; NONHUMAN; OSMOTIC STRESS; PATHOGENESIS; PERIPHERAL NERVE; POLYNEUROPATHY; RETINOPATHY; SCIATIC NERVE; SOCIOECONOMICS; STAINING; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; COST; DIABETIC FOOT; ECONOMICS; FEMALE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW; SALIVA; SECRETION; UNITED STATES; WOMEN'S HEALTH;

COSTS AND COST ANALYSIS; DIABETES, GESTATIONAL; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY IN DIABETICS; SALIVA; SOCIOECONOMIC FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 0036599336     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.6.1085     Document Type: Conference Paper

References (33)

1. Ito T, Nishimura C, Takahashi Y, Saito T, Omori Y: The level of erythrocyte aldose reductase: a risk factor for diabetic neuropathy? Diabetes Res Clin Pract 36:161-167, 1997
2. ε-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients. Diabetes Care 23:1539-1544, 2000
3. Greene DA, Arezzo JC, Brown MB: Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy: Zenarestat Study Group. Neurology 53:580-591, 1999
4. Hotta N, Toyota T, Matsuoka K, Shigeta Y, Kikkawa R, Kaneko T, Takahashi A, Sugimura K, Koike Y, Ishii J, Sakamoto N: Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 24:1776-1782, 2001
5. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
6. Muller-Felber W, Landgraf R, Wagner S, Mair N, Nusser J, Landgraf-Leurs MM, Abendroth A, Illner WD, Land W: Follow-up study of sensory-motor polyneuropathy in type 1 (insulin-dependent) diabetic subjects after simultaneous pancreas and kidney transplantation and after graft rejection. Diabetologia 34 (Suppl. 1):S113-S117, 1991
7. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA: Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomie neuropathies. N Engl J Med 343:847-855, 2000
8. Aberg A, Westbom L, Kallen B: Congenital malformations among infants whose mothers had gestational diabetes or pre-existing diabetes. Early Hum Dev 61:85-95, 2001
9. Suhonen L, Hiilesmaa V, Teramo K: Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 43:79-82, 2000
10. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, Platt MJ, Stanisstreet M, van Velszen D, Walkinshaw S: Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315:275-278, 1997
11. Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL: Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 182:313-320, 2000
12. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, Buchanan TA: Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 18:1446-1451, 1995
13. McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PS, Tsang RC: A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 9:14-20, 2000
14. Eriksson UJ, Borg LA: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991
15. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Gates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
16. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L: Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354:810-816, 1999
17. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, Metzger B, Bieber FR, Knopp RH, Holmes LB: Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319: 1617-1623, 1988
18. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, Reed GF, Bieber FR: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318:671-676, 1988
19. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD: Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 265:731-736, 1991
20. Jovanovic-Peterson L, Durak EP, Peterson CM: Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Am J Obstet Gynecol 161:415-419, 1989
21. Langer O, Rodriguez DA, Xenakis EM, McFarland MB, Berkus MD, Arrendondo F: Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 170:1036-1046, 1994
22. Coetzee EJ, Jackson WP: Diabetes newly diagnosed during pregnancy: a 4-year study at Groote Schuur Hospital. S Afr Med J 56:467-475, 1979
23. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O: A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343:1134-1138, 2000
24. Peppard HR, Marfori J, Iuorno MJ, Nestler JE: Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care 24:1050-1052, 2001
25. Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, Blackard WG: Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68:1027-1032, 1989
26. Nestler JE, Jakubowicz DJ: Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 335:617-623, 1996
27. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R: Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338:1876-1880, 1998
28. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M: Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85:139-146, 2000
29. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O'Keefe M, Ghazzi MN, PCOS/Troglitazone Study Group: Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86:1626-1632, 2001
30. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS: Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23:1278-1283, 2000
31. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS: The continuing increase of diabetes in the US (Letter). Diabetes Care 24:412, 2001
32. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J: Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT: MRFIT Research Group: Multiple Risk Factor Intervention Trial. Lancet 351:934-939, 1998
33. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA: Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 312:406-410, 1996